Impact of a Video-Based Educational Intervention on the Levels of Knowledge and Concerns about COVID-19 Vaccination
Abstract
:1. Introduction
2. Methods
2.1. Study Design
2.2. Study Participants
2.3. Educational Intervention
2.4. Data Collection Methods and Outcome Measures
2.5. Data Analysis
2.6. Ethical Considerations
3. Results
3.1. Personal and COVID-19-Related Characteristics
3.2. Knowledge about COVID-19 Vaccination
Concerns about COVID-19 Vaccination
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Rahman, M.d.M.; Chisty, M.A.; Alam, M.d.A.; Sakib, M.S.; Quader, M.A.; Shobuj, I.A.; Halim, M.A.; Rahman, F. Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh. PLoS ONE 2022, 17, e0270684. [Google Scholar] [CrossRef] [PubMed]
- Tsai, R.; Hervey, J.; Hoffman, K.; Wood, J.; Johnson, J.; Deighton, D.; Clermont, D.; Loew, B.; Golgberg, S.L. COVID-19 vaccine hesitancy and acceptance among in-dividuals with cancer, autoimmune diseases, and other serious comorbid conditions: A cross-sectional internet-based survey. JMIR Public Health Surveill. 2021, 8, e29872. [Google Scholar] [CrossRef] [PubMed]
- Leigh, P.J.; Moss, S.J.; White, T.M.; Picchio, C.A.; Rabin, K.H.; Ratzan, S.C.; Wyka, K.; El-Mohandes, A.; Lazarus, J.V. Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries. Vaccine 2022, 40, 4081–4089. [Google Scholar] [CrossRef] [PubMed]
- Abolfotouh, M.A.; Almutairi, A.F.; Banimustafa, A.; Hagras, S.A.; Al Jeraisy, M. Behavior responses and attitude of the public to COVID-19 pandemic during movement restrictions in Saudi Arabia. Int. J. Gen. Med. 2021, 14, 741–753. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 2020, 27, 225–228. Available online: https://www.nature.com/articles/s41591-020-1124-9 (accessed on 1 April 2021). [CrossRef] [PubMed]
- Fridman, A.; Gershon, R.; Gneezy, A. COVID-19 and vaccine hesitancy: A longitudinal study. PLoS ONE 2021, 16, e0250123. [Google Scholar] [CrossRef]
- Batteux, E.; Mills, F.; Jones, L.F.; Symons, C.; Weston, D. The Effectiveness of interventions for increasing COVID-19 vaccine uptake: A systematic review. Vaccines 2022, 10, 386. [Google Scholar] [CrossRef]
- El-Elimat, T.; AbuAlSamen, M.M.; Almomani, B.A.; Al-Sawalha, N.A.; Alali, F.Q. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. PLoS ONE 2021, 16, e0250555. Available online: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250555 (accessed on 23 April 2021). [CrossRef]
- Qunaibi, E.; Basheti, I.; Soudy, M.; Sultan, I. Hesitancy of arab healthcare workers towards COVID-19 vaccination: A large-scale multinational study. Vaccines 2021, 9, 446. [Google Scholar] [CrossRef]
- Zhu, P.; Tatar, O.; Griffin-Mathieu, G.; Perez, S.; Haward, B.; Zimet, G.; Tunis, M.; Dubé, È.; Rosberger, Z. Efficacy of a brief, altruism-eliciting video intervention in enhancing COVID-19 vaccination intentions amongst a population-based sample of younger adults: Randomized con-trolled trial. JMIR Public Health Surveill. 2022, 8, e37328. [Google Scholar] [CrossRef]
- Davis, C.J.; Golding, M.; McKay, R. Efficacy information influences intention to take COVID-19 vaccine. Br. J. Health Psychol. 2021, 27, 300–319. [Google Scholar] [CrossRef] [PubMed]
- Witus, L.S.; Larson, E. A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention. PLoS ONE 2022, 17, e0267580. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.; Alsofayan, Y.; Alahmari, A.; Alowais, J.; Algwizani, A.; Alserehi, H.; Assiri, A.; Jokhdar, H. COVID-19 in Saudi Arabia: The national health response. East. Mediterr. Health J. 2021, 27, 1114–1124. [Google Scholar] [CrossRef] [PubMed]
- Al-Mohaithef, M.; Padhi, B.K. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey. J. Multidiscip. Health 2020, 13, 1657–1663. [Google Scholar] [CrossRef] [PubMed]
- Alqahtani, Y.S. Acceptability of the COVID-19 vaccine among adults in Saudi Arabia: A cross-sectional study of the general population in the Southern Region of Saudi Arabia. Vaccines 2021, 10, 41. [Google Scholar] [CrossRef]
- Alfageeh, E.I.; Alshareef, N.; Angawi, K.; Alhazmi, F.; Chirwa, G.C. Acceptability of a COVID-19 vaccine among the Saudi Population. Vaccines 2021, 9, 226. Available online: https://www.mdpi.com/2076-393X/9/3/226/htm (accessed on 3 December 2022). [CrossRef]
- Troiano, G.; Nardi, A. Vaccine hesitancy in the era of COVID-19. Public Health 2021, 194, 245–251. [Google Scholar] [CrossRef]
- Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef]
- Dhama, K.; Sharun, K.; Tiwari, R.; Dhawan, M.; Bin Emran, T.; Rabaan, A.A.; Alhumaid, S. COVID-19 vaccine hesitancy–reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum. Vaccines Immunother. 2021, 17, 3495–3499. [Google Scholar] [CrossRef]
- Al-Hanawi, M.K.; Angawi, K.; Alshareef, N.; Qattan, A.M.N.; Helmy, H.Z.; Abudawood, Y.; Alqurashi, M.; Kattan, W.M.; Kadasah, N.A.; Chirwa, G.C.; et al. Knowledge, Attitude and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Front. Public Health 2020, 8, 217. [Google Scholar] [CrossRef]
- Bazaid, A.S.; Aldarhami, A.; Binsaleh, N.K.; Sherwani, S.; Althomali, O.W. Knowledge and practice of personal protective measures during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia. PLoS ONE 2020, 15, e0243695. [Google Scholar] [CrossRef] [PubMed]
- Alanazi, N.; Bahjri, K. Knowledge, Attitude, and Psychological Impacts of COVID-19 in Saudi Arabia. Front. Public Health 2022, 10, 801777. [Google Scholar] [CrossRef]
- Abolfotouh, M.A.; Almutairi, A.F.; BaniMustafa, A.A.; Hussein, M.A. Perception and attitude of healthcare workers in Saudi Arabia with regard to Covid-19 pandemic and potential associated predictors. BMC Infect. Dis. 2020, 20, 719. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. COVID-19 Vaccines; World Health Organization: Geneva, Switzerland, 2021.
- CDC. Myths and Facts about COVID-19 Vaccines; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2021. Available online: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/facts.html (accessed on 11 August 2021).
- Ministry of Health. Kingdom of Saudi Arabia-Ministry of Health Portal. 2019. Available online: https://www.moh.gov.sa/en/Pages/default.aspx (accessed on 11 August 2021).
- MNGHA. COVID-19 Vaccination Center. 2020. Available online: https://ngha.med.sa/Arabic/Pages/covid19center.aspx (accessed on 19 February 2023).
- Martin, L.R.; Petrie, K.J. Understanding the dimensions of anti-vaccination attitudes: The vaccination attitudes examination (VAX) scale. Ann. Behav. Med. 2017, 51, 652–660. [Google Scholar] [CrossRef]
- Ren, X.; Shen, F.; Gui, Y.; Wang, W.; Xing, B.; Huang, W. The attitudes of psychiatric patients towards COVID-19 vaccination in China: A cross-sectional study. BMC Psychiatry 2021, 21, 475. [Google Scholar] [CrossRef]
- Sonmezer, M.C.; Sahin, T.K.; Erul, E.; Ceylan, F.S.; Hamurcu, M.Y.; Morova, N.; Al, I.R.; Unal, S. Knowledge, attitudes, and perception towards COVID-19 vaccination among the adult population: A cross-sectional study in Turkey. Vaccines 2022, 10, 278. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877322/ (accessed on 11 February 2022). [CrossRef] [PubMed]
- Abebe, H.; Shitu, S.; Mose, A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect. Drug Resist. 2021, 14, 2015–2025. [Google Scholar] [CrossRef]
- AlGethami, H.; Altamran, M.; Khan, M.; Zaman, K.; Alswaied, N. Awareness and knowledge towards pediatric and adult COVID-19 vaccination: A cross sectional community-based study in Saudi Arabia. Mater. Socio-Med. 2021, 33, 262–268. [Google Scholar] [CrossRef]
- Almalki, M.J. Knowledge, attitudes, and practices toward COVID-19 among the general public in the border region of Jazan, Saudi Arabia: A cross-sectional study. Front. Public Health 2021, 9, 733125. [Google Scholar] [CrossRef]
- Al-Zalfawi, S.M.; Rabbani, S.I.; Asdaq, S.M.B.; Alamri, A.S.; Alsanie, W.F.; Alhomrani, M.; Mohzari, Y.; Alrashed, A.A.; AlRifdah, A.H.; Almagrabe, T. Public knowledge, attitude, and per-ception towards COVID-19 vaccination in Saudi Arabia. Int. J. Environ. Res. Public Health 2021, 18, 10081. Available online: https://www.mdpi.com/1660-4601/18/19/10081 (accessed on 1 January 2023). [CrossRef]
- Dai, H.; Saccardo, S.; Han, M.A.; Roh, L.; Raja, N.; Vangala, S.; Modi, H.; Pandya, S.; Sloyan, M.; Croymans, D.M. Behavioural nudges increase COVID-19 vaccinations. Nature 2021, 597, 404–409. [Google Scholar] [CrossRef] [PubMed]
- Duch, R.; Roope, L.S.J.; Violato, M.; Becerra, M.F.; Robinson, T.S.; Bonnefon, J.-F.; Friedman, J.; Loewen, P.J.; Mamidi, P.; Melegaro, A.; et al. Citizens from 13 countries share similar pref-erences for COVID-19 vaccine allocation priorities. Proc. Natl. Acad. Sci. USA 2021, 118, e2026382118. [Google Scholar] [CrossRef] [PubMed]
- Alrowaily, M.A.; Alkhathlan, T.K.; Alaql, A.B.; Almesned, I.S.; Alrowaily, H.M.; Alayed, N.A.; Abolfotouh, M.A. Assessment of level of concern about vaccination among recovered COVID-19 patients in Riyadh, Saudi Arabia. East. Mediterr. Health J. 2023, 29. [Google Scholar] [CrossRef]
- Zahid, H.; Alsayb, M. Assessing the knowledge and attitude toward COVID-19 vaccination in Saudi Arabia. Int. J. Environ. Res. Public Health 2021, 18, 8185. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346133/ (accessed on 1 December 2021). [CrossRef]
- Mahmud, S.; Mohsin; Khan, I.A.; Mian, A.U.; Zaman, M.A. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLoS ONE 2021, 16, e0257096. [Google Scholar] [CrossRef]
- Cordina, M.; Lauri, M.A.; Lauri, J. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine. Pharm. Pract. 2021, 19, 2317. [Google Scholar] [CrossRef]
- Zhu, J.-H.; Li, W.; Huo, X.-N.; Jin, H.-M.; Zhang, C.-H.; Yun, J.-D.; Gao, L.-G.; Cheung, T.; Hall, B.J.; Yang, B.; et al. The attitude towards preventive measures and knowledge of COVID-19 inpatients with severe mental illness in economically underdeveloped areas of China. Psychiatr. Q. 2020, 92, 683–691. [Google Scholar] [CrossRef]
- Meraya, A.M.; Salami, R.M.; Alqahtani, S.S.; Madkhali, O.A.; Hijri, A.M.; Qassadi, F.A.; Albarrati, A.M. COVID-19 vaccines and restrictions: Concerns and opinions among individuals in Saudi Arabia. Healthcare 2022, 10, 816. [Google Scholar] [CrossRef]
- Chen, J.S.; Alfajaro, M.M.; Chow, R.D.; Wei, J.; Filler, R.B.; Eisenbarth, S.C.; Wilen, C.B. Nonsteroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. J. Virol. 2021, 95, e00014-21. [Google Scholar] [CrossRef]
- Adane, M.; Ademas, A.; Kloos, H. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia. BMC Public Health 2022, 22, 128. [Google Scholar] [CrossRef]
- Hong, J.; Xu, X.; Yang, J.; Zheng, J.; Dai, S.; Zhou, J.; Zhang, Q.M.; Ruan, Y.; Ling, C.Q. Knowledge about, attitude and acceptance towards, and predictors of in-tention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. J. Integr. Med. 2022, 20, 34–44. [Google Scholar] [CrossRef] [PubMed]
- Abolfotouh, M.A. Behaviour disorders among urban schoolboys in south-western Saudi Arabia. East. Mediterr. Health J. 1997, 3, 274–283. [Google Scholar] [CrossRef]
- Kaliyadan, F.; Al Ameer, M.A.; Al Ameer, A.; Al Alwan, Q. Telemedicine practice in Saudi Arabia during the COVID-19 pandemic. Cureus 2020, 12, e12004. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Experimental Group | Control Group | χ2 | p-Value | ||
---|---|---|---|---|---|---|
No (253) | % | No (255) | % | |||
Personal characteristics | ||||||
Gender | ||||||
Female | 113 | 44.7 | 81 | 31.8 | 8.95 | 0.003 * |
Male | 140 | 55.3 | 174 | 68.2 | ||
Age | ||||||
Less than 45 years | 222 | 87.7 | 222 | 87.1 | 0.06 | 0.82 |
45 years or more | 31 | 12.3 | 33 | 12.9 | ||
Education | ||||||
Secondary or less | 65 | 25.7 | 70 | 27.5 | 0.20 | 0.65 |
University or above | 188 | 74.3 | 185 | 72.5 | ||
Marital Status | ||||||
Single | 120 | 47.4 | 114 | 44.9 | 5.77 | 0.12 |
Married | 97 | 38.3 | 119 | 46.7 | ||
Widowed | 5 | 2.0 | 3 | 1.2 | ||
Divorced | 31 | 12.3 | 19 | 7.5 | ||
Monthly Income | ||||||
Low | 88 | 34.8 | 68 | 26.7 | 4.25 | 0.12 |
Medium | 132 | 52.2 | 145 | 56.9 | ||
High | 33 | 13.0 | 42 | 16.5 | ||
Pregnancy Status (females only) | ||||||
Yes | 18 | 37.5 | 12 | 22.2 | 2.86 | 0.09 |
No | 30 | 62.5 | 42 | 77.8 | ||
Working in Medical Field | ||||||
Yes | 78 | 30.8 | 92 | 36.1 | 1.57 | 0.21 |
No | 175 | 69.2 | 163 | 63.9 | ||
COVID-19-related characteristics | ||||||
COVID-19 Symptoms | ||||||
Yes | 55 | 21.7 | 48 | 18.8 | 0.67 | 0.41 |
No | 198 | 78.3 | 207 | 81.2 | ||
Allergies to COVID-19 Vaccines | ||||||
Yes | 37 | 14.6 | 37 | 14.5 | 0.001 | 0.97 |
No | 216 | 85.4 | 218 | 85.5 | ||
Phobia of Needles | ||||||
Yes | 34 | 13.4 | 34 | 13.3 | 0.001 | 0.97 |
No | 219 | 86.6 | 221 | 86.7 | ||
Taking Any Anti-inflammatory | ||||||
Yes | 62 | 24.5 | 11 | 4.3 | 42.08 | <0.001 * |
No | 191 | 75.5 | 244 | 95.7 | ||
Taking Any Blood Anticoagulants | ||||||
Yes | 23 | 9.1 | 14 | 5.5 | 2.44 | 0.12 |
No | 230 | 90.9 | 241 | 94.5 | ||
Taking Any Immune-suppressive | ||||||
Yes | 34 | 13.4 | 20 | 7.8 | 4.19 | 0.041 * |
No | 219 | 86.6 | 235 | 92.2 | ||
Taking Any Antipsychotics | ||||||
Yes | 32 | 12.6 | 23 | 9.0 | 1.73 | 0.19 |
No | 221 | 87.4 | 232 | 91.0 |
Level of Knowledge | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Knowledge Domains | Poor (Less than 50%) | Average (50–75%) | Good (More than 75%) | χ2 | p-Value | PMS (SD) | t-Value | p-Value | |||
N | % | N | % | N | % | ||||||
Vaccine Mechanisms | |||||||||||
Control Group | 83 | 32.5 | 61 | 23.9 | 111 | 43.5 | 113.68 | <0.001 | 68.2 ± 24.0 | −11.35 * | <0.001 |
Experimental Group | 28 | 11.1 | 4 | 1.6 | 221 | 87.4 | 90.8 ± 21.0 | ||||
Rumors | |||||||||||
Control Group | 144 | 56.5 | 20 | 7.8 | 91 | 35.7 | 85.56 | <0.001 | 53.2 ± 38.5 | −8.92 * | <0.001 |
Experimental Group | 44 | 17.4 | 24 | 9.5 | 185 | 73.1 | 82.1 ± 34.3 | ||||
Vaccine Formation Process | |||||||||||
Control Group | 145 | 56.9 | 95 | 37.3 | 15 | 5.9 | 48.72 | <0.001 | 43.1 ± 28.3 | −4.37 * | <0.001 |
Experimental Group | 67 | 26.5 | 166 | 65.6 | 20 | 7.9 | 54.3 ± 29.2 | ||||
COVID-19 Vaccines in Saudi Arabia | |||||||||||
Control Group | 180 | 70.6 | 55 | 21.6 | 20 | 7.8 | 70.72 | <0.001 | 51.1 ± 17.1 | −6.30 * | <0.001 |
Experimental Group | 88 | 34.8 | 93 | 36.8 | 72 | 28.5 | 62.2 ± 22.2 | ||||
Overall Knowledge | |||||||||||
Control Group | 82 | 32.2 | 162 | 63.5 | 11 | 4.3 | 249.26 | <0.001 | 55.7 ± 14.3 | −11.59 * | <0.001 |
Experimental Group | 33 | 13.0 | 38 | 15.1 | 182 | 71.9 | 74.2 ± 21.0 |
Level of Concern | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Concern Domain | Low (Less than 50%) | Moderate (50–75%) | High (More than 75%) | χ2 | p-Value | PMS (SD) | t-Value | p-Value | |||
No | % | No | % | No | % | ||||||
Mistrust | |||||||||||
Control Group | 15 | 5.9 | 203 | 79.6 | 37 | 14.5 | 306.14 | < 0.001 | 66.4 ± 15.1 | 24.76 * | <0.001 |
Experimental Group | 210 | 83.0 | 36 | 14.2 | 7 | 2.8 | 38.1 ± 10.0 | ||||
Worries | |||||||||||
Control Group | 33 | 12.9 | 193 | 75.7 | 29 | 11.4 | 22.65 | <0.001 | 63.6 ±11.1 | 5.18 * | <0.001 |
Experimental Group | 32 | 12.6 | 218 | 86.2 | 3 | 1.2 | 59.2 ± 7.7 | ||||
Commercial Profiteering | |||||||||||
Control Group | 33 | 12.9 | 165 | 64.7 | 57 | 22.4 | 192.19 | <0.001 | 66.2 ± 13.7 | 19.93 * | <0.001 |
Experimental Group | 179 | 70.8 | 74 | 29.2 | 0 | 0.0% | 44.0 ± 11.3 | ||||
Preference for Natural Immunity | |||||||||||
Control Group | 43 | 16.9 | 179 | 70.2 | 33 | 12.9 | 191.42 | <0.001 | 63.8 ± 13.0 | 18.11 * | <0.001 |
Experimental Group | 197 | 77.9 | 42 | 16.6 | 14 | 5.5 | 38.7 ± 17.9 | ||||
Overall Concern | |||||||||||
Control Group | 1 | 0.4 | 240 | 94.1 | 14 | 5.5 | 313.44 | <0.001 | 65.0 ± 6.6 | 28.85 * | <0.001 |
Experimental Group | 194 | 76.7 | 58 | 22.9 | 1 | 0.4 | 45.0 ± 8.8 |
Knowledge Score | Concern Score | |||||
---|---|---|---|---|---|---|
B (SE) | t-Value | p-Value | B (SE) | t-Value | p-Value | |
Study Group (experimental = 1) | 17.09 (1.67) | 10.24 | <0.001 * | 119.45 (0.72) | −27.00 | <0.001 * |
Gender (female = 1) | 0.84 (1.65) | 0.51 | 0.61 | 0.65 (0.71) | 0.91 | 0.36 |
Anti-inflammatory drugs (yes = 1) | 5.10 (2.36) | 2.16 | 0.03 * | −1.83 (1.02) | −1.79 | 0.08 |
Immune-suppressive drugs (yes = 1) | 4.45 (2.58) | 1.72 | 0.09 | −3.09 ((1.12) | −2.76 | 0.006 * |
Constant | 54.87 (1.25) | 43.81 | <0.001 | 65.11 (0.54) | 119.91 | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Barnawi, N.A.; Alraqei, B.; Hilwan, A.; Al-Otibi, M.; Alsubaie, R.; Altowymy, S.; Abolfotouh, M.A. Impact of a Video-Based Educational Intervention on the Levels of Knowledge and Concerns about COVID-19 Vaccination. Vaccines 2023, 11, 727. https://doi.org/10.3390/vaccines11040727
Barnawi NA, Alraqei B, Hilwan A, Al-Otibi M, Alsubaie R, Altowymy S, Abolfotouh MA. Impact of a Video-Based Educational Intervention on the Levels of Knowledge and Concerns about COVID-19 Vaccination. Vaccines. 2023; 11(4):727. https://doi.org/10.3390/vaccines11040727
Chicago/Turabian StyleBarnawi, Najla A., Basmah Alraqei, Ashwaq Hilwan, Maram Al-Otibi, Roaya Alsubaie, Shahad Altowymy, and Mostafa A. Abolfotouh. 2023. "Impact of a Video-Based Educational Intervention on the Levels of Knowledge and Concerns about COVID-19 Vaccination" Vaccines 11, no. 4: 727. https://doi.org/10.3390/vaccines11040727
APA StyleBarnawi, N. A., Alraqei, B., Hilwan, A., Al-Otibi, M., Alsubaie, R., Altowymy, S., & Abolfotouh, M. A. (2023). Impact of a Video-Based Educational Intervention on the Levels of Knowledge and Concerns about COVID-19 Vaccination. Vaccines, 11(4), 727. https://doi.org/10.3390/vaccines11040727